rspНаучно-практическая ревматологияRheumatology Science and Practice1995-44841995-4492IMA-PRESS, LLC10.47360/1995-4484-2026-249-257rsp-3942Research ArticleМЕЖДУНАРОДНЫЕ И РОССИЙСКИЕ РЕКОМЕНДАЦИИ ПО ЛЕЧЕНИЮ РЕВМАТИЧЕСКИХ ЗАБОЛЕВАНИЙINTERNATIONAL AND RUSSIAN GUIDELINES FOR THE TREATMENT OF RHEUMATIC DISEASESЕвразийский консенсус ревматологов по диагностике и лечению системной красной волчанкиEurasian Consensus of Rheumatologists on the diagnosis and treatment of systemic lupus erythematosushttps://orcid.org/0000-0002-7842-1871ТогизбаевГ. А.TogizbaevG. A.

05000, Алматы, ул. Айтеке би, 120 

05000, Almaty, Aiteke Bi str., 120

https://orcid.org/0000-0003-3261-1036БаймухамедовЧ. Т.BaimukhamedovCh. T.

160019, Шымкент, пл. Аль-Фараби, 1

160019, Shymkent, Al-Faraby square, 1

https://orcid.org/0000-0002-4630-3985ИсаеваБ. Г.IssayevaB. G.

050012, Алматы, ул. Толе би, 94

050012, Almaty, Tole Bi str., 94

https://orcid.org/0009-0000-0224-6520ОмарбековаЖ. Е.OmarbekovaZh. E.

010000, Астана, ул. Сыганак, 46 

010000, Astana, Syganak str., 46 

https://orcid.org/0000-0001-5433-3300КойлубаеваГ. М.KoylubaevaG. M.

115522, Бишкек, ул. Тоголока Молдо, 3 

115522, Bishkek, Togoloka Moldo str., 3 

https://orcid.org/0000-0002-8031-9083ЛобанченкоО. В.LobanchenkoO. V.

720010, Бишкек, ул. Табышалиева, 34

720010, Kyrgyz Republic, Bishkek, Tabyshalieva str., 34

https://orcid.org/0000-0002-8222-4344МартусевичН. А.MartusevichN. A.

220083, Минск, просп. Дзержинского, 83

220083, Minsk, Dzerzhinskogo avenue, 83

https://orcid.org/0009-0006-6978-3754ЧижК. А.ChizhK. A.

220083, Минск, просп. Дзержинского, 83

220083, Minsk, Dzerzhinskogo avenue, 83

https://orcid.org/0009-0006-6058-0977ШукуроваС. М.ShukurovaS. M.

734026, Душанбе, просп. Исмоили Сомони, 59

734026, Dushanbe, Ismoili Somoni avenue, 59

https://orcid.org/0009-0001-6536-1427АроянА. А.HaroyanA. A.

0087, Ереван, ул. Титоградяна, 14 

0087, Yerevan, Titogradyana str., 14 

https://orcid.org/0009-0009-3295-5892ХамроеваЗ.KhamroevaZ.

70022, Баку, ул. Бакиханова, 23

70022, Baku, Bakikhanova str., 23 

https://orcid.org/0000-0002-6052-1727ГусейновН.HuseinovN.

0025, Ереван, ул. Корюна, 2

0025, Yerevan, Koryuna str., 2

https://orcid.org/0000-0002-1598-8360НасоновЕ. Л.NasonovE. L.

115522, Москва, Каширское шоссе, 34а

115522, Moscow, Kashirskoye Highway, 34A

https://orcid.org/0000-0001-5793-4689ПопковаТ. В.PopkovaT. V.

115522, Москва, Каширское шоссе, 34а

115522, Moscow, Kashirskoye Highway, 34A

https://orcid.org/0000-0003-1053-6952ПанафидинаТ. А.PanafidinaT. A.

115522, Москва, Каширское шоссе, 34а

115522, Moscow, Kashirskoye Highway, 34A

https://orcid.org/0000-0002-5206-1732СоловьевС. К.SolovyevS. K.

115522, Москва, Каширское шоссе, 34а

115522, Moscow, Kashirskoye Highway, 34A

https://orcid.org/0000-0002-1663-7810АсееваЕ. А.AseevaE. A.

Асеева Елена Александровна

115522, Москва, Каширское шоссе, 34

115522, Moscow, Kashirskoye Highway, 34A

eaasseeva@mail.ruhttps://orcid.org/0000-0003-3552-2522РешетнякТ. М.ReshetnyakT. M.

115522, Москва, Каширское шоссе, 34

115522, Moscow, Kashirskoye Highway, 34A

https://orcid.org/0000-0002-7879-1522НабиеваД. А.NabievaD. A.

100109, Ташкент, ул. Фароби, 2 

100109, Tashkent, Farobi str., 2

https://orcid.org/0000-0003-4544-8485МирахмедоваХ. Т.MirakhmedovaH. T.

100109, Ташкент, ул. Фароби, 2 

100109, Tashkent, Farobi str., 2

https://orcid.org/0000-0002-8241-8501ГиносянК. В.GinosyanK. V.

0025, Ереван, ул. Корюна, 2 

0025, Yerevan, Koryuna str., 2

АО «Научно-исследовательский институт кардиологии и внутренних болезней»КазахстанResearch Institute of Cardiology and Internal DiseasesKazakhstanАО «Южно-Казахстанская медицинская академия»КазахстанSouth Kazakhstan Medical AcademyKazakhstanНАО «Казахский национальный медицинский университет имени С.Д. Асфендиярова»КазахстанKazakh National Medical University named after S.D. AsfendiyarovKazakhstanАО «Республиканский диагностический центр»КазахстанRepublican Diagnostic CenterKazakhstanНациональный центр кардиологии и терапии имени академика Мирсаида Миррахимова при Министерстве здравоохранения Кыргызской РеспубликиКыргызстанNational Center of Cardiology and Therapy named after academician Mirsaid Mirrahimov under the Ministry of Health of the Kyrgyz RepublicKyrgyzstanООО «Центр костно-суставной патологии ЛиК»КыргызстанCenter for Bone and Joint Pathology LiKKyrgyzstanУО «Белорусский государственный медицинский университет»БеларусьBelarusian State Medical UniversityBelarusИнститут последипломного образования в сфере здравоохранения Республики ТаджикистанТаджикистанInstitute of Postgraduate Education in Healthcare of the Republic of TajikistanTajikistanМедицинский центр «Эребуни»АрменияErebuni Medical CenterArmeniaАзербайджанский медицинский университетАзербайджанAzerbaijan Medical UniversityAzerbaijanЕреванский государственный медицинский университет имени Мхитара ГерациАрменияYerevan State Medical University named after Mkhitar HeratsiArmeniaФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»РоссияV.A. Nasonova Research Institute of RheumatologyRussian FederationТашкентский государственный медицинский университетУзбекистанTashkent State Medical UniversityUzbekistanЕреванский государственный медицинский университет имени Мхитара ГерациАрменияYerevan State Medical University namedafte r Mkhitar HeratsiArmenia202630062026643249257Copyright © Тогизбаев Г.А., Баймухамедов Ч.Т., Исаева Б.Г., Омарбекова Ж.Е., Койлубаева Г.М., Лобанченко О.В., Мартусевич Н.А., Чиж К.А., Шукурова С.М., Ароян А.А., Хамроева З., Гусейнов Н., Насонов Е.Л., Попкова Т.В., Панафидина Т.А., Соловьев С.К., Асеева Е.А., Решетняк Т.М., Набиева Д.А., Мирахмедова Х.Т., Гиносян К.В., 20262026Тогизбаев Г.А., Баймухамедов Ч.Т., Исаева Б.Г., Омарбекова Ж.Е., Койлубаева Г.М., Лобанченко О.В., Мартусевич Н.А., Чиж К.А., Шукурова С.М., Ароян А.А., Хамроева З., Гусейнов Н., Насонов Е.Л., Попкова Т.В., Панафидина Т.А., Соловьев С.К., Асеева Е.А., Решетняк Т.М., Набиева Д.А., Мирахмедова Х.Т., Гиносян К.В.Togizbaev G.A., Baimukhamedov C.T., Issayeva B.G., Omarbekova Z.E., Koylubaeva G.M., Lobanchenko O.V., Martusevich N.A., Chizh K.A., Shukurova S.M., Haroyan A.A., Khamroeva Z., Huseinov N., Nasonov E.L., Popkova T.V., Panafidina T.A., Solovyev S.K., Aseeva E.A., Reshetnyak T.M., Nabieva D.A., Mirakhmedova H.T., Ginosyan K.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://rsp.mediar-press.net/rsp/article/view/3942

Группой ведущих ревматологов стран СНГ подготовлены клинические рекомендации по диагностике, лечению и мониторингу системной красной волчанки. Клинические рекомендации подготовлены с учетом рекомендаций национальных ассоциаций ревматологов стран СНГ, международных рекомендаций Европейского альянса ассоциаций ревматологов и Американской коллегии ревматологов. Данные рекомендации предназначены для широкого круга специалистов стран СНГ, ревматологов, терапевтов.

A group of leading rheumatologists from the Commonwealth of Independent States (CIS) countries has prepared clinical guidelines for the diagnosis, treatment, and monitoring of systemic lupus erythematosus. These clinical guidelines are based on the recommendations of the national rheumatology associations of the CIS countries, the international guidelines of the European Alliance of Associations for Rheumatology, and the American College of Rheumatology. These guidelines are intended for a wide range of specialists in the CIS countries, including rheumatologists and general practitioners.

системная красная волчанкарекомендацииsystemic lupus erythematosusrecommendationsИсследование не имело спонсорской поддержки.ReferencesNandakumar KS, Nündel K. Editorial: Systemic lupus erythematosus – predisposition factors, pathogenesis, diagnosis, treatment and disease models. Front Immunol. 2022;13:1118180. doi: 10.3389/fimmu.2022.1118180Nandakumar KS, Nündel K. Editorial: Systemic lupus erythematosus – predisposition factors, pathogenesis, diagnosis, treatment and disease models. Front Immunol. 2022;13:1118180. doi: 10.3389/fimmu.2022.1118180Yu H, Nagafuchi Y, Fujio K. Clinical and immunological biomarkers for systemic lupus erythematosus. Biomolecules. 2021;11(7):928. doi: 10.3390/biom11070928Yu H, Nagafuchi Y, Fujio K. Clinical and immunological biomarkers for systemic lupus erythematosus. Biomolecules. 2021;11(7):928. doi: 10.3390/biom11070928Kiriakidou M, Ching C. Systemic lupus erythematosus. Ann Intern Med. 2020;172:81-96. doi: 10.7326/AITC202006020Kiriakidou M, Ching C. Systemic lupus erythematosus. Ann Intern Med. 2020;172:81-96. doi: 10.7326/AITC202006020lsen NJ, Karp DR. Autoantibodies and SLE: The threshold for disease. Nat Rev Rheumatol. 2014;10:181-186. doi: 10.1038/nrrheum.2013.184lsen NJ, Karp DR. Autoantibodies and SLE: The threshold for disease. Nat Rev Rheumatol. 2014;10:181-186. doi: 10.1038/nrrheum.2013.184Izmirly PM, Parton H, Wang L, McCune WJ, Lim SS, Drenkard C, et al. Prevalence of systemic lupus erythematosus in the United States: Estimates from a meta-analysis of the Centers for Disease Control and Prevention National Lupus Registries. Arthritis Rheumatol. 2021;73(6):991-996. doi: 10.1002/art.41632Izmirly PM, Parton H, Wang L, McCune WJ, Lim SS, Drenkard C, et al. Prevalence of systemic lupus erythematosus in the United States: Estimates from a meta-analysis of the Centers for Disease Control and Prevention National Lupus Registries. Arthritis Rheumatol. 2021;73(6):991-996. doi: 10.1002/art.41632Nasonov E, Soloviev S, Davidson JE, Lila A, Togizbayev G, Ivanova R, et al. Standard medical care of patients with systemic lupus erythematosus (SLE) in large specialised centres: Data from the Russian Federation, Ukraine and Republic of Kazakhstan (ESSENCE). Lupus Sci Med. 2015;2(1):e000060. doi: 10.1136/lupus-2014-000060Nasonov E, Soloviev S, Davidson JE, Lila A, Togizbayev G, Ivanova R, et al. Standard medical care of patients with systemic lupus erythematosus (SLE) in large specialised centres: Data from the Russian Federation, Ukraine and Republic of Kazakhstan (ESSENCE). Lupus Sci Med. 2015;2(1):e000060. doi: 10.1136/lupus-2014-000060Nasonov E, Soloviev S, Davidson JE, Lila A, Togizbayev G, Ivanova R, et al. Systemic lupus erythematosus and associated healthcare resource consumption in selected cities from the Russian Federation, Republic of Kazakhstan and Ukraine: The ESSENCE study. J Med Econ. 2018;21(10):1006-1015. doi: 10.1080/13696998.2018.1499518Nasonov E, Soloviev S, Davidson JE, Lila A, Togizbayev G, Ivanova R, et al. Systemic lupus erythematosus and associated healthcare resource consumption in selected cities from the Russian Federation, Republic of Kazakhstan and Ukraine: The ESSENCE study. J Med Econ. 2018;21(10):1006-1015. doi: 10.1080/13696998.2018.1499518Siegel CH, Sammaritano LR. Systemic lupus erythematosus: A review. JAMA. 2024;331(17):1480-1491. doi: 10.1001/jama.2024.2315Siegel CH, Sammaritano LR. Systemic lupus erythematosus: A review. JAMA. 2024;331(17):1480-1491. doi: 10.1001/jama.2024.2315Hoi A, Igel T, Mok CC, Arnaud L. Systemic lupus erythematosus. Lancet. 2024;403(10441):2326-2338. doi: 10.1016/S0140-6736(24)00398-2Hoi A, Igel T, Mok CC, Arnaud L. Systemic lupus erythematosus. Lancet. 2024;403(10441):2326-2338. doi: 10.1016/S0140-6736(24)00398-2Cervera R. Systemic lupus erythematosus criteria nowadays. Med Clin (Barc). 2022;159(4):187-188. doi: 10.1016/j.medcli.2022.04.002Cervera R. Systemic lupus erythematosus criteria nowadays. Med Clin (Barc). 2022;159(4):187-188. doi: 10.1016/j.medcli.2022.04.002Системная красная волчанка: клинические рекомендации. М.;2025. URL: https://cr.minzdrav.gov.ru/viewcr/484_2 (Accessed: 27 November 2025).Systemic lupus erythematosus: Clinical guidelines. Moscow;2025 (In Russ.). URL: https://cr.minzdrav.gov.ru/viewcr/484_2 (Accessed: 27 November 2025).Lindblom J, Mohan C, Parodis I. Diagnostic, predictive and prognostic biomarkers in systemic lupus erythematosus: Current insights. Curr Opin Rheumatol. 2022;34(2):139-149. doi: 10.1097/BOR.0000000000000862Lindblom J, Mohan C, Parodis I. Diagnostic, predictive and prognostic biomarkers in systemic lupus erythematosus: Current insights. Curr Opin Rheumatol. 2022;34(2):139-149. doi: 10.1097/BOR.0000000000000862Chitpet P, Chaiamnuay S, Narongroeknawin P, Asavatanabodee P, Leosuthamas P, Pakchotanon R. The effect of systemic lupus erythematosus (SLE) Disease Activity Score and SLE Disease Activity Index 2000-based remission states in patients with SLE on damage accrual. Int J Rheum Dis. 2023;26(12):2509- 2516. doi: 10.1111/1756-185X.14949Chitpet P, Chaiamnuay S, Narongroeknawin P, Asavatanabodee P, Leosuthamas P, Pakchotanon R. The effect of systemic lupus erythematosus (SLE) Disease Activity Score and SLE Disease Activity Index 2000-based remission states in patients with SLE on damage accrual. Int J Rheum Dis. 2023;26(12):2509- 2516. doi: 10.1111/1756-185X.14949Banjari M, Touma Z, Gladman DD. Improving measures of disease activity in systemic lupus erythematosus. Expert Rev Clin Immunol. 2023;19(2):193-202. doi: 10.1080/1744666X.2023.2156339Banjari M, Touma Z, Gladman DD. Improving measures of disease activity in systemic lupus erythematosus. Expert Rev Clin Immunol. 2023;19(2):193-202. doi: 10.1080/1744666X.2023.2156339Kapsala N, Nikolopoulos D, Flouda S, Chavatza A, Tseronis D, Aggelakos M, et al. First diagnosis of systemic lupus erythematosus in hospitalized patients: Clinical phenotypes and pitfalls for the non-specialist. Am J Med. 2022;135(2):244-253.e3. doi: 10.1016/j.amjmed.2021.07.015Kapsala N, Nikolopoulos D, Flouda S, Chavatza A, Tseronis D, Aggelakos M, et al. First diagnosis of systemic lupus erythematosus in hospitalized patients: Clinical phenotypes and pitfalls for the non-specialist. Am J Med. 2022;135(2):244-253.e3. doi: 10.1016/j.amjmed.2021.07.015Bane S, Falasinnu T, Espinosa PR, Simard JF. Misdiagnosis, missed diagnosis, and delayed diagnosis of lupus: A qualitative study of rheumatologists. Arthritis Care Res (Hoboken). 2024;76(11):1566-1573. doi: 10.1002/acr.25405Bane S, Falasinnu T, Espinosa PR, Simard JF. Misdiagnosis, missed diagnosis, and delayed diagnosis of lupus: A qualitative study of rheumatologists. Arthritis Care Res (Hoboken). 2024;76(11):1566-1573. doi: 10.1002/acr.25405Stull C, Sprow G, Werth VP. Cutaneous involvement in systemic lupus erythematosus: A review for the rheumatologist. J Rheumatol. 2023;50(1):27-35. doi: 10.3899/jrheum.220089Stull C, Sprow G, Werth VP. Cutaneous involvement in systemic lupus erythematosus: A review for the rheumatologist. J Rheumatol. 2023;50(1):27-35. doi: 10.3899/jrheum.220089Jarukitsopa S, Hoganson DD, Crowson CS, Sokumbi O, Davis MD, Michet CJ Jr, et al. Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States. Arthritis Care Res (Hoboken). 2015;67(6):817-828. doi: 10.1002/acr.22502Jarukitsopa S, Hoganson DD, Crowson CS, Sokumbi O, Davis MD, Michet CJ Jr, et al. Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States. Arthritis Care Res (Hoboken). 2015;67(6):817-828. doi: 10.1002/acr.22502Kuhn A, Landmann A. The classification and diagnosis of cutaneous lupus erythematosus. J Autoimmun. 2014;48:14-19. doi: 10.1016/j.jaut.2014.01.021Kuhn A, Landmann A. The classification and diagnosis of cutaneous lupus erythematosus. J Autoimmun. 2014;48:14-19. doi: 10.1016/j.jaut.2014.01.021Smiljanić Tomičević L, Barešić M, Mayer M, Anić B. Musculoskeletal manifestations of systemic lupus erythematosus. Acta Clin Croat. 2023;62(4):714-723. doi: 10.20471/acc.2023.62.04.18Smiljanić Tomičević L, Barešić M, Mayer M, Anić B. Musculoskeletal manifestations of systemic lupus erythematosus. Acta Clin Croat. 2023;62(4):714-723. doi: 10.20471/acc.2023.62.04.18Grossman JM. Lupus arthritis. Best Pract Res Clin Rheumatol. 2009;23(4):495-506. doi: 10.1016/j.berh.2009.04.003Grossman JM. Lupus arthritis. Best Pract Res Clin Rheumatol. 2009;23(4):495-506. doi: 10.1016/j.berh.2009.04.003Ozbek S, Sert M, Paydas S, Soy M. Delay in the diagnosis of SLE: The importance of arthritis/arthralgia as the initial symptom. Acta Med Okayama. 2003;57(4):187-190. doi: 10.18926/AMO/32807Ozbek S, Sert M, Paydas S, Soy M. Delay in the diagnosis of SLE: The importance of arthritis/arthralgia as the initial symptom. Acta Med Okayama. 2003;57(4):187-190. doi: 10.18926/AMO/32807Ball EMA, Bell AL. Lupus arthritis – do we have a clinically useful classification? Rheumatology (Oxford). 2012;51(5):771-779. doi: 10.1093/rheumatology/ker381Ball EMA, Bell AL. Lupus arthritis – do we have a clinically useful classification? Rheumatology (Oxford). 2012;51(5):771-779. doi: 10.1093/rheumatology/ker381Pego-Reigosa JM, Cobo-Ibáñez T, Calvo-Alén J, Loza-Santamaría E, Rahman A, Muñoz-Fernández S, et al. Efficacy and safety of nonbiologic immunosuppressants in the treatment of nonrenal systemic lupus erythematosus: A systematic review. Arthritis Care Res (Hoboken). 2013;65(11):1775-1185. doi: 10.1002/acr.22035Pego-Reigosa JM, Cobo-Ibáñez T, Calvo-Alén J, Loza-Santamaría E, Rahman A, Muñoz-Fernández S, et al. Efficacy and safety of nonbiologic immunosuppressants in the treatment of nonrenal systemic lupus erythematosus: A systematic review. Arthritis Care Res (Hoboken). 2013;65(11):1775-1185. doi: 10.1002/acr.22035Rahman P, Humphrey-Murto S, Gladman DD, Urowitz MB. Efficacy and tolerability of methotrexate in antimalarial resistant lupus arthritis. J Rheumatol. 1998;25(2):243-246.Rahman P, Humphrey-Murto S, Gladman DD, Urowitz MB. Efficacy and tolerability of methotrexate in antimalarial resistant lupus arthritis. J Rheumatol. 1998;25(2):243-246.Aguilera-Pickens G, Abud-Mendoza C. Pulmonary manifestations in systemic lupus erythematosus: Pleural involvement, acute pneumonitis, chronic interstitial lung disease and diffuse alveolar hemorrhage. Reumatol Clin (Engl Ed). 2018;14(5):294-300. doi: 10.1016/j.reuma.2018.03.012Aguilera-Pickens G, Abud-Mendoza C. Pulmonary manifestations in systemic lupus erythematosus: Pleural involvement, acute pneumonitis, chronic interstitial lung disease and diffuse alveolar hemorrhage. Reumatol Clin (Engl Ed). 2018;14(5):294-300. doi: 10.1016/j.reuma.2018.03.012Bendstrup E, Lynn E, Troldborg A. Systemic lupus erythematosusrelated lung disease. Semin Respir Crit Care Med. 2024;45(3):386- 396. doi: 10.1055/s-0044-1782653Bendstrup E, Lynn E, Troldborg A. Systemic lupus erythematosusrelated lung disease. Semin Respir Crit Care Med. 2024;45(3):386- 396. doi: 10.1055/s-0044-1782653Piga M, Parodis I, Touma Z, Legge A, Ugarte-Gil MF, Hmamouchi I, et al. Framework for implementing treat-to-target in systemic lupus erythematosus routine clinical care: Consensus statements from an international task force. Autoimmun Rev. 2025;24(5):103773. doi: 10.1016/j.autrev.2025.103773Piga M, Parodis I, Touma Z, Legge A, Ugarte-Gil MF, Hmamouchi I, et al. Framework for implementing treat-to-target in systemic lupus erythematosus routine clinical care: Consensus statements from an international task force. Autoimmun Rev. 2025;24(5):103773. doi: 10.1016/j.autrev.2025.103773Nikolopoulos D, Lourenço MH, Depascale R, Triantafyllias K, Parodis I. Evolving concepts in treat-to-target strategies for systemic lupus erythematosus. Mediterr J Rheumatol. 2024;35(Suppl 2):328-341. doi: 10.31138/mjr.290424.eciNikolopoulos D, Lourenço MH, Depascale R, Triantafyllias K, Parodis I. Evolving concepts in treat-to-target strategies for systemic lupus erythematosus. Mediterr J Rheumatol. 2024;35(Suppl 2):328-341. doi: 10.31138/mjr.290424.eciGonzález-García A, Cusácovich I, Ruiz-Irastorza G. Treatment of systemic lupus erythematosus: New therapeutic options. Rev Clin Esp (Barc). 2023;223(10):629-639. doi: 10.1016/j.rceng.2023.11.001González-García A, Cusácovich I, Ruiz-Irastorza G. Treatment of systemic lupus erythematosus: New therapeutic options. Rev Clin Esp (Barc). 2023;223(10):629-639. doi: 10.1016/j.rceng.2023.11.001Porta S, Danza A, Arias Saavedra M, Carlomagno A, Goizueta MC, Vivero F, et al. Glucocorticoids in systemic lupus erythematosus. Ten questions and some issues. J Clin Med. 2020;9:2709. doi: 10.3390/jcm9092709Porta S, Danza A, Arias Saavedra M, Carlomagno A, Goizueta MC, Vivero F, et al. Glucocorticoids in systemic lupus erythematosus. Ten questions and some issues. J Clin Med. 2020;9:2709. doi: 10.3390/jcm9092709Apostolopoulos D, Morand EF. It hasn’t gone away: The problem of glucocorticoid use in lupus remains. Rheumatology (Oxford). 2017;56:114-122. doi: 10.1093/rheumatology/kew406Apostolopoulos D, Morand EF. It hasn’t gone away: The problem of glucocorticoid use in lupus remains. Rheumatology (Oxford). 2017;56:114-122. doi: 10.1093/rheumatology/kew406Amissah-Arthur MB, Gordon C. Contemporary treatment of systemic lupus erythematosus: An update for clinicians. Ther Adv Chronic Dis. 2010;1:163-175. doi: 10.1177/2040622310380100Amissah-Arthur MB, Gordon C. Contemporary treatment of systemic lupus erythematosus: An update for clinicians. Ther Adv Chronic Dis. 2010;1:163-175. doi: 10.1177/2040622310380100Fanouriakis A, Kostopoulou M, Andersen J, Aringer M, Arnaud L, Bae SC, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis. 2024;83(1):15-29. doi: 10.1136/ard-2023-224762Fanouriakis A, Kostopoulou M, Andersen J, Aringer M, Arnaud L, Bae SC, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis. 2024;83(1):15-29. doi: 10.1136/ard-2023-224762Fanouriakis A, Kostopoulou M, Anders HJ, Andersen J, Aringer M, Beresford MW, et al. EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 update. Ann Rheum Dis. 2026;85(1):75-90. doi: 10.1016/j.ard.2025.09.007Fanouriakis A, Kostopoulou M, Anders HJ, Andersen J, Aringer M, Beresford MW, et al. EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 update. Ann Rheum Dis. 2026;85(1):75-90. doi: 10.1016/j.ard.2025.09.007Huang WN, Chen MH, Hsieh SC, Lu LY, Wu YJ, Tsai CY, et al. The Taiwan College of Rheumatology consensus for the management of systemic lupus erythematosus. Int J Rheum Dis. 2026;29(1):e70530. doi: 10.1111/1756-185x.70530Huang WN, Chen MH, Hsieh SC, Lu LY, Wu YJ, Tsai CY, et al. The Taiwan College of Rheumatology consensus for the management of systemic lupus erythematosus. Int J Rheum Dis. 2026;29(1):e70530. doi: 10.1111/1756-185x.70530Primo-Gabriel C, García-Gómez C, Calvo-Alén J. Systematic literature review of intravenous immunoglobulin use in non-renal and non-hematologic systemic lupus erytehmatosus. Lupus. 2025;34(3):261-269. doi: 10.1177/09612033251319402Primo-Gabriel C, García-Gómez C, Calvo-Alén J. Systematic literature review of intravenous immunoglobulin use in non-renal and non-hematologic systemic lupus erytehmatosus. Lupus. 2025;34(3):261-269. doi: 10.1177/09612033251319402Насонов ЕЛ, Решетняк TM, Бекетова ТВ, Сукмарова ЗН, Старкова АС. Внутривенный иммуноглобулин в ревматологии: новые данные и проект клинических рекомендаций. Научно-практическая ревматология. 2025;63(6):559-575. doi: 10.47360/1995-4484-2025-559-575Nasonov EL, Reshetnyak TM, Beketova TV, Sukmarova ZN, Starkova AS. Intravenous immunoglobulin in rheumatology: New data and draft clinical guidelines. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2025;63(6):559-575 (In Russ.). doi: 10.47360/1995-4484-2025-559-575Huang J, Fan W, Chen X, Wu S, Dong Z, Zhang Y, et al. Case report: Rituximab combined with plasma exchange treatment for systemic lupus erythematosus complicated with thrombotic microangiopathy and non-cirrhotic portal hypertension. Front Immunol. 2025;15:1475303. doi: 10.3389/fimmu.2024.1475303Huang J, Fan W, Chen X, Wu S, Dong Z, Zhang Y, et al. Case report: Rituximab combined with plasma exchange treatment for systemic lupus erythematosus complicated with thrombotic microangiopathy and non-cirrhotic portal hypertension. Front Immunol. 2025;15:1475303. doi: 10.3389/fimmu.2024.1475303Kagitani M, Fujiki Y, Suzuka T, Ooe K, Sakamoto A, Takeuchi T, et al. A successful plasma exchange in bridging to rituximab for severe neuropsychiatric lupus and lupus nephritis with viral infections and aspiration pneumonia. Mod Rheumatol Case Rep. 2024;8(2):276-279. doi: 10.1093/mrcr/rxad069Kagitani M, Fujiki Y, Suzuka T, Ooe K, Sakamoto A, Takeuchi T, et al. A successful plasma exchange in bridging to rituximab for severe neuropsychiatric lupus and lupus nephritis with viral infections and aspiration pneumonia. Mod Rheumatol Case Rep. 2024;8(2):276-279. doi: 10.1093/mrcr/rxad069Sammaritano LR, Askanase A, Bermas BL, Dall’Era M, DuarteGarcía A, Hiraki LT, et al. 2024 American College of Rheumatology (ACR) guideline for the screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken). 2025;77(9):1045-1065. doi: 10.1002/acr.25528Sammaritano LR, Askanase A, Bermas BL, Dall’Era M, DuarteGarcía A, Hiraki LT, et al. 2024 American College of Rheumatology (ACR) guideline for the screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken). 2025;77(9):1045-1065. doi: 10.1002/acr.25528Papachristos DA, Oon S, Hanly JG, Nikpour M. Management of inflammatory neurologic and psychiatric manifestations of systemic lupus erythematosus: systematic review. Semin Arthritis Rheum. 2021;51(1):49-71. doi: 10.1016/j.semarthrit.2020.12.004Papachristos DA, Oon S, Hanly JG, Nikpour M. Management of inflammatory neurologic and psychiatric manifestations of systemic lupus erythematosus: systematic review. Semin Arthritis Rheum. 2021;51(1):49-71. doi: 10.1016/j.semarthrit.2020.12.004Magro-Checa C, Zirkzee EJ, Huizinga TW, Steup-Beekman GM. Management of neuropsychiatric systemic lupus erythematosus: Current approaches and future perspectives. Drugs. 2016;76(4):459- 483. doi: 10.1007/s40265-015-0534-3Magro-Checa C, Zirkzee EJ, Huizinga TW, Steup-Beekman GM. Management of neuropsychiatric systemic lupus erythematosus: Current approaches and future perspectives. Drugs. 2016;76(4):459- 483. doi: 10.1007/s40265-015-0534-3Лисицына ТА, Вельтищев ДЮ, Серавина ОФ, Ковалевская ОВ, Марченко АС, Насонов ЕЛ. Варианты психических нарушений у больных системной красной волчанкой. Научно-практическая ревматология. 2008;46(4):21-26. doi: 10.14412/1995-4484-2008-531Lisitsyna TA, Veltishev DY, Seravina OF, Kovalevskaya OB, Marchenko AS, Nasonov EL. Variants of psychiatric disorders in patients with systemic lupus erythematosus. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2008;46(4):21-26 (In Russ.). doi: 10.14412/1995-4484-2008-531Шалыгина МВ, Попкова ТВ, Волков АВ, Кириллова ИГ. Ранний предиктор высокого сердечно-сосудистого риска при системной красной волчанке. Научно-практическая ревматология. 2025;63(6):604-610. doi: 10.47360/1995-4484-2025-604-610Shalygina MV, Popkova TV, Volkov AV, Kirillova IG. Early predictor of high cardiovascular risk in systemic lupus erythematosus. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2025;63(6):604-610 (In Russ.). doi: 10.47360/1995-4484-2025-604-610Насонов ЕЛ, Соловьев СК, Аршинов АВ. Системная красная волчанка: история и современность. Научно-практическая ревматология. 2022;60(4):397-412. doi: 10.47360/1995-4484-2022-397-41Nasonov EL, Soloviev SK, Arshinov AV. Systemic lupus erythematosus: History and modernity. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2022;60(4):397-412 (In Russ.). doi: 10.47360/1995-4484-2022-397-41Cheldieva FA, Reshetnyak TM, Shumilova AA, Nurbaeva KS, Cherkasova MV, Lila AM, et al. Global Antiphospholipid Syndrome Score (GAPSS) in patients with systemic lupus erythematosus. Dokl Biochem Biophys. 2023;511(1):227-234. doi: 10.1134/S160767292370028XCheldieva FA, Reshetnyak TM, Shumilova AA, Nurbaeva KS, Cherkasova MV, Lila AM, et al. Global Antiphospholipid Syndrome Score (GAPSS) in patients with systemic lupus erythematosus. Dokl Biochem Biophys. 2023;511(1):227-234. doi: 10.1134/S160767292370028XFrostegård J. Systemic lupus erythematosus and cardiovascular disease. J Intern Med. 2023;293(1):48-62. doi: 10.1111/joim.13557Frostegård J. Systemic lupus erythematosus and cardiovascular disease. J Intern Med. 2023;293(1):48-62. doi: 10.1111/joim.13557Giannakaki AG, Giannakaki MN, Bothou A, Nikolettos K, Machairiotis N, Pappa KI, et al. Current approaches to the management of rheumatic diseases in pregnancy: Risk stratification, therapeutic advances, and maternal-fetal outcomes. J Pers Med. 2025;15(9):406. doi: 10.3390/jpm15090406Giannakaki AG, Giannakaki MN, Bothou A, Nikolettos K, Machairiotis N, Pappa KI, et al. Current approaches to the management of rheumatic diseases in pregnancy: Risk stratification, therapeutic advances, and maternal-fetal outcomes. J Pers Med. 2025;15(9):406. doi: 10.3390/jpm15090406McDonald EG, Bissonette L, Ensworth S, Dayan N, Clarke AE, Keeling S, et al. Monitoring of systemic lupus erythematosus pregnancies: A systematic literature review. J Rheumatol. 2018;45(10):1477-1490. doi: 10.3899/jrheum.171023McDonald EG, Bissonette L, Ensworth S, Dayan N, Clarke AE, Keeling S, et al. Monitoring of systemic lupus erythematosus pregnancies: A systematic literature review. J Rheumatol. 2018;45(10):1477-1490. doi: 10.3899/jrheum.171023Colquhoun M, Thanopoulou V, Quick V, Mouyis M. Rituximab administration during the second trimester of pregnancy for systemic lupus erythematosus: Case report and review of the literature on rheumatic disease. Mod Rheumatol Case Rep. 2022;6(2):173- 177. doi: 10.1093/mrcr/rxab051Colquhoun M, Thanopoulou V, Quick V, Mouyis M. Rituximab administration during the second trimester of pregnancy for systemic lupus erythematosus: Case report and review of the literature on rheumatic disease. Mod Rheumatol Case Rep. 2022;6(2):173- 177. doi: 10.1093/mrcr/rxab051Bass AR, Chakravarty E, Akl EA, Bingham CO, Calabrese L, Cappelli LC, et al. 2022 American College of Rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases. Arthritis Care Res (Hoboken). 2023;75(3):449-464. doi: 10.1002/acr.25045Bass AR, Chakravarty E, Akl EA, Bingham CO, Calabrese L, Cappelli LC, et al. 2022 American College of Rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases. Arthritis Care Res (Hoboken). 2023;75(3):449-464. doi: 10.1002/acr.25045Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, van Assen S, Bijl M, et al. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2020;79(1):39-52. doi: 10.1136/annrheumdis-2019-215882Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, van Assen S, Bijl M, et al. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2020;79(1):39-52. doi: 10.1136/annrheumdis-2019-215882Белов БС, Соловьев СК, Тарасова ГМ, Асеева ЕА. Вакцинация у больных системной красной волчанкой: результаты и перспективы. Научно-практическая ревматология. 2018;56(3):373-379. doi: 10.14412/1995-4484-2018-373-379Belov BS, Solovyev SK, Tarasova GM, Aseeva EA. Vaccination in patients with systemic lupus erythematosus: Results and prospects. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2018;56(3):373-379 (In Russ.). 2018;56(3):373-379. doi: 10.14412/1995-4484-2018-373-379Насонов ЕЛ, Румянцев АГ, Самсонов МЮ. Фармакотерапия аутоиммунных ревматических заболеваний – от моноклональных антител к CAR-T-клеткам: 20 лет спустя. Научно-практическая ревматология. 2024;62(3):262-279. doi: 10.47360/1995-4484-2024-262-279Nasonov EL, Rumyantsev AG, Samsonov MYu. Pharmacotherapy of autoimmune rheumatic diseases – from monoclonal antibodies to CAR T cells: 20 years later. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2024;62(3):262-279 (In Russ.). doi: 10.47360/1995-4484-2024-262-279

The authors declare that there are no conflicts of interest present.